Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Tedeschi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Research|November 9, 2012
Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumorsAlexei Vazquez, Philip M Tedeschi, Joseph R Bertino
Molecular Cancer Research : MCR|June 24, 2015
Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug DevelopmentPhilip M Tedeschi, Alexei Vazquez, John E Kerrigan, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2014
Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenograftsPhilip M Tedeschi, Yamini K Kathari, Iqra N Farooqi, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2015
Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combinationPhilip M Tedeschi, Yamini K Kathari, Nadine Johnson-Farley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.
Molecular Pharmacology|July 30, 2015
Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyPhilip M Tedeschi, HongXia Lin, Murugesan Gounder, et al.
Cancer & Metabolism|November 28, 2013
The metabolic demands of cancer cells are coupled to their size and protein synthesis ratesSonia C Dolfi, Leo Li-Ying Chan, Jean Qiu, et al.
Cancer & Metabolism|May 30, 2015
Quantification of folate metabolism using transient metabolic flux analysisPhilip M Tedeschi, Nadine Johnson-Farley, Hongxia Lin, et al.
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Research|November 9, 2012
Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumorsAlexei Vazquez, Philip M Tedeschi, Joseph R Bertino
Molecular Cancer Research : MCR|June 24, 2015
Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug DevelopmentPhilip M Tedeschi, Alexei Vazquez, John E Kerrigan, et al.
Oncotarget|February 6, 2016
MTHFD2--a new twist?Philip M Tedeschi, Kathleen W Scotto, John Kerrigan, et al.
Cancer Chemotherapy and Pharmacology|September 11, 2014
Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenograftsPhilip M Tedeschi, Yamini K Kathari, Iqra N Farooqi, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2015
Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combinationPhilip M Tedeschi, Yamini K Kathari, Nadine Johnson-Farley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2016
NAD+ Kinase as a Therapeutic Target in CancerPhilip M Tedeschi, Nitu Bansal, John E Kerrigan, et al.
Molecular Pharmacology|July 30, 2015
Suppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyPhilip M Tedeschi, HongXia Lin, Murugesan Gounder, et al.
Cancer & Metabolism|November 28, 2013
The metabolic demands of cancer cells are coupled to their size and protein synthesis ratesSonia C Dolfi, Leo Li-Ying Chan, Jean Qiu, et al.
Cancer & Metabolism|May 30, 2015
Quantification of folate metabolism using transient metabolic flux analysisPhilip M Tedeschi, Nadine Johnson-Farley, Hongxia Lin, et al.
Nature Communications|January 26, 2016
Functional annotation of rare gene aberration drivers of pancreatic cancerYiu Huen Tsang, Turgut Dogruluk, Philip M Tedeschi, et al.
Pageof 1